Seer, Inc.
NASDAQ:SEER
Overview | Financials
Company Name | Seer, Inc. |
Symbol | SEER |
Currency | USD |
Price | 2.31 |
Market Cap | 136,212,747 |
Dividend Yield | 0% |
52-week-range | 1.51 - 2.625 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Omid C. Farokhzad M.D., Ph.D. |
Website | https://seer.bio |
An error occurred while fetching data.
About Seer, Inc.
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD